Pediatric Thoracic Empyema—Outcomes of Intrapleural Thrombolytics: Ten Years of Experience
Introduction . Pediatric thoracic empyema is a special entity with increasing frequency. Consensus regarding the best management strategy is still evolving. We describe our single-center 10-year experience adopting intrapleural thrombolytics using tissue plasminogen activator as first-line treatment...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-06-01
|
Series: | Global Pediatric Health |
Online Access: | https://doi.org/10.1177/2333794X20928200 |